Altimmune (ALT) Profit After Tax: 2010-2025
Historic Profit After Tax for Altimmune (ALT) over the last 16 years, with Sep 2025 value amounting to -$19.0 million.
- Altimmune's Profit After Tax rose 16.77% to -$19.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$83.9 million, marking a year-over-year increase of 18.94%. This contributed to the annual value of -$95.1 million for FY2024, which is 7.48% down from last year.
- Latest data reveals that Altimmune reported Profit After Tax of -$19.0 million as of Q3 2025, which was up 14.14% from -$22.1 million recorded in Q2 2025.
- Altimmune's Profit After Tax's 5-year high stood at -$14.9 million during Q1 2021, with a 5-year trough of -$33.5 million in Q3 2021.
- In the last 3 years, Altimmune's Profit After Tax had a median value of -$22.1 million in 2025 and averaged -$22.2 million.
- Per our database at Business Quant, Altimmune's Profit After Tax crashed by 282.54% in 2021 and then climbed by 29.82% in 2022.
- Altimmune's Profit After Tax (Quarterly) stood at -$23.9 million in 2021, then increased by 9.33% to -$21.7 million in 2022, then plummeted by 46.08% to -$31.6 million in 2023, then climbed by 26.74% to -$23.2 million in 2024, then climbed by 16.77% to -$19.0 million in 2025.
- Its Profit After Tax stands at -$19.0 million for Q3 2025, versus -$22.1 million for Q2 2025 and -$19.6 million for Q1 2025.